Increased Expression of HIF2α During Iron Deficiency-associated Megakaryocytic Differentiation

Overview

Journal J Thromb Haemost

Publisher Elsevier

Specialty Hematology

Date 2015 Feb 26

PMID 25715026

Citations 17

Authors

K Jimenez

V Khare

R Evstatiev

S Kulnigg-Dabsch

M Jambrich

H Strobl

C Gasche

Affiliations

Soon will be listed here.

Abstract

Background: Iron deficiency is associated with reactive thrombocytosis; however, the mechanisms driving this phenomenon remain unclear. We previously demonstrated that this occurs alongside enhanced megakaryopoiesis in iron-deficient rats, without alterations in the megakaryopoietic growth factors thrombopoietin, interleukin-6, or interleukin-11.

Objectives: The aim of this study was to evaluate megakaryocyte differentiation under iron deficiency in an in vitro model and to investigate potential genes involved in this process.

Methods: Human erythroleukemia and megakaryoblastic leukemia cell lines, as well as cord-blood derived hematopoietic stem cells were cultured under iron deficiency. Cell morphology, ploidy, expression of CD41, CD61, and CD42b, and proplatelet formation were assessed in iron-deficient cultures. Polymerase chain reaction arrays were used to identify candidate genes that were verified using real-time polymerase chain reaction. Hypoxia-inducible factor 1, α subunit (HIF2α) protein expression was assessed in bone marrow sections from iron-deficient rats and vascular endothelial growth factor (VEGF)-A in culture supernatants.

Results And Conclusions: Iron deficiency enhanced megakaryoid features in cell lines, increasing ploidy and initiating formation of proplatelet-like structures. In cord blood cell cultures, iron deficiency increased the percentage of cells expressing megakaryopoietic markers and enhanced proplatelet formation. HIF2α and VEGF were identified as potential pathways involved in this process. HIF2α protein expression was increased in megakaryocytes from iron-deficient rats, and VEGF-A concentration was higher in iron-deficient culture supernatants. Addition of VEGF-A to cell cultures increased percentage expression of megakaryocyte CD41. In conclusion, the data demonstrate that iron deficiency augments megakaryocytic differentiation and proplatelet formation and a potential role of HIF2α in megakaryopoiesis.

Citing Articles

Oxymatrine, a novel TLR2 agonist, promotes megakaryopoiesis and thrombopoiesis through the STING/NF-κB pathway.

Ni C, Zhou L, Yang S, Ran M, Luo J, Cheng K J Pharm Anal. 2025; 15(1):101054.

PMID: 39906691 PMC: 11791361. DOI: 10.1016/j.jpha.2024.101054.

Genistin: A Novel Estrogen Analogue Targeting ERβ to Alleviate Thrombocytopenia.

Tang X, Liao R, Zhou L, Yi T, Ran M, Luo J Int J Biol Sci. 2024; 20(6):2236-2260.

PMID: 38617546 PMC: 11008259. DOI: 10.7150/ijbs.90483.

Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.

Zhou L, Ni C, Liao R, Tang X, Yi T, Ran M Elife. 2024; 13.

PMID: 38573820 PMC: 10994662. DOI: 10.7554/eLife.94765.

Thrombotic Alterations under Perinatal Hypoxic Conditions: HIF and Other Hypoxic Markers.

Berna-Erro A, Granados M, Rosado J, Redondo P Int J Mol Sci. 2023; 24(19).

PMID: 37833987 PMC: 10572648. DOI: 10.3390/ijms241914541.

JAK2 V617F allele burden in polycythemia vera: burden of proof.

Moliterno A, Kaizer H, Reeves B Blood. 2023; 141(16):1934-1942.

PMID: 36745865 PMC: 10163319. DOI: 10.1182/blood.2022017697.

References

Long M, Heffner C, Williams J, Peters C, Prochownik E . Regulation of megakaryocyte phenotype in human erythroleukemia cells. J Clin Invest. 1990; 85(4):1072-84. PMC: 296537. DOI: 10.1172/JCI114538. View

Balduini A, Pallotta I, Malara A, Lova P, Pecci A, Viarengo G . Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. J Thromb Haemost. 2008; 6(11):1900-7. DOI: 10.1111/j.1538-7836.2008.03132.x. View

Lebedeva E, Yushkov B, Chereshnev V . Megakaryocytopoiesis under hypoxic conditions. Bull Exp Biol Med. 2004; 136(6):554-6. DOI: 10.1023/b:bebm.0000020201.51742.28. View

Kaushansky K . Historical review: megakaryopoiesis and thrombopoiesis. Blood. 2008; 111(3):981-6. PMC: 2214745. DOI: 10.1182/blood-2007-05-088500. View

Novacek G, Weltermann A, Sobala A, Tilg H, Petritsch W, Reinisch W . Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology. 2010; 139(3):779-87, 787.e1. DOI: 10.1053/j.gastro.2010.05.026. View

Avecilla S, Hattori K, Heissig B, Tejada R, Liao F, Shido K . Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med. 2004; 10(1):64-71. DOI: 10.1038/nm973. View

Eliades A, Matsuura S, Ravid K . Oxidases and reactive oxygen species during hematopoiesis: a focus on megakaryocytes. J Cell Physiol. 2012; 227(10):3355-62. PMC: 3357446. DOI: 10.1002/jcp.24071. View

Raslova H, Roy L, Vourch C, Le Couedic J, Brison O, Metivier D . Megakaryocyte polyploidization is associated with a functional gene amplification. Blood. 2002; 101(2):541-4. DOI: 10.1182/blood-2002-05-1553. View

Maguire J, deVeber G, Parkin P . Association between iron-deficiency anemia and stroke in young children. Pediatrics. 2007; 120(5):1053-7. DOI: 10.1542/peds.2007-0502. View

10.

Lordier L, Jalil A, Aurade F, Larbret F, Larghero J, Debili N . Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling. Blood. 2008; 112(8):3164-74. DOI: 10.1182/blood-2008-03-144956. View

11.

Calero-Nieto F, Wood A, Wilson N, Kinston S, Landry J, Gottgens B . Transcriptional regulation of Elf-1: locus-wide analysis reveals four distinct promoters, a tissue-specific enhancer, control by PU.1 and the importance of Elf-1 downregulation for erythroid maturation. Nucleic Acids Res. 2010; 38(19):6363-74. PMC: 2965225. DOI: 10.1093/nar/gkq490. View

12.

Baribeault D, Auerbach M . Iron replacement therapy in cancer-related anemia. Am J Health Syst Pharm. 2011; 68(10 Suppl 1):S4-14. DOI: 10.2146/ajhp110039. View

13.

Shah Y, Xie L . Hypoxia-inducible factors link iron homeostasis and erythropoiesis. Gastroenterology. 2014; 146(3):630-42. PMC: 3943938. DOI: 10.1053/j.gastro.2013.12.031. View

14.

Sato T, Fuse A, Eguchi M, Hayashi Y, Ryo R, Adachi M . Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia. Br J Haematol. 1989; 72(2):184-90. DOI: 10.1111/j.1365-2141.1989.tb07681.x. View

15.

Choi S, Simone J, Jackson C . Megakaryocytopoiesis in experimental iron deficiency anemia. Blood. 1974; 43(1):111-20. View

16.

Kulnigg-Dabsch S, Evstatiev R, Dejaco C, Gasche C . Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia. PLoS One. 2012; 7(4):e34520. PMC: 3323537. DOI: 10.1371/journal.pone.0034520. View

17.

Chang Y, Hung S, Ling W, Lin H, Li H, Chung S . Association between ischemic stroke and iron-deficiency anemia: a population-based study. PLoS One. 2013; 8(12):e82952. PMC: 3857285. DOI: 10.1371/journal.pone.0082952. View

18.

Klimchenko O, Mori M, Distefano A, Langlois T, Larbret F, Lecluse Y . A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. Blood. 2009; 114(8):1506-17. DOI: 10.1182/blood-2008-09-178863. View

19.

Casey J, Hentze M, Koeller D, Caughman S, Rouault T, Klausner R . Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science. 1988; 240(4854):924-8. DOI: 10.1126/science.2452485. View

20.

Italiano Jr J, Patel-Hett S, Hartwig J . Mechanics of proplatelet elaboration. J Thromb Haemost. 2007; 5 Suppl 1:18-23. DOI: 10.1111/j.1538-7836.2007.02487.x. View